Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.07%
1,101.37
-0.81
-0.07%
—1,102.181,096.241,103.051,090.35——
SIXC
Communications
SIXC
Communications
SIXC
-0.47%
613.35
-2.89
-0.47%
—616.24616.24617.68609.10——
SIXE
Energy
SIXE
Energy
SIXE
+0.77%
1,198.83
+9.11
+0.77%
—1,189.721,194.741,202.791,188.58——
SIXI
Industrials
SIXI
Industrials
SIXI
+1.75%
1,755.95
+30.26
+1.75%
—1,725.691,730.021,762.991,730.02——
SIXM
Financials
SIXM
Financials
SIXM
-0.79%
638.51
-5.11
-0.79%
—643.62643.13643.17632.59——
SIXR
Staples
SIXR
Staples
SIXR
+1.65%
843.52
+13.73
+1.65%
—829.79832.32845.25832.32——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.19%
215.95
+2.55
+1.19%
—213.40213.40216.07213.40——
SIXT
Technology
SIXT
Technology
SIXT
-1.48%
3,138.91
-47.01
-1.48%
—3,185.923,160.893,178.723,102.60——
SIXU
Utilities
SIXU
Utilities
SIXU
+2.80%
934.37
+25.43
+2.80%
—908.94912.57934.91912.57——
SIXV
Health care
SIXV
Health care
SIXV
-0.10%
1,477.43
-1.53
-0.10%
—1,478.961,478.171,482.911,466.65——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.05%
2,380.19
-25.17
-1.05%
—2,405.362,390.342,402.532,359.18——
DIVISLAB:NSE
Divi's Laboratories Ltd
₹6,384.50
+0.09%
(+6.00) 1D
Apr 24, 10:14:36 AM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for DIVISLAB...
Open
₹6,408.50
High
₹6,442.50
Low
₹6,376.50
Mkt. cap
1.69T
Avg. vol.
256.20K
Volume
109.47K
Dividend
0.47%
Quarterly dividend
₹7.50
Ex dividend date
Jul 25, 2025
P/E ratio
68.32
52-wk high
₹7,071.50
52-wk low
₹5,636.50
EPS
₹93.45
Shares outstanding
265.47M
No. of employees
11K
News stories
From sources across the web
Profile
Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients and intermediates, headquartered in Hyderabad. The company manufactures and custom synthesizes generic APIs, intermediates. The company also manufactures and supplies nutraceutical ingredients through its subsidiary, Divi's Nutraceuticals. Divi's Laboratories is India's fourth largest publicly listed pharmaceutical company by market capitalization. Wikipedia
About Divi's Laboratories Ltd
CEOKiran S. Divi
Employees10.5K
FoundedOct 12, 1990
Headquarters-
SectorHealth care
Websitedivislabs.com
Last report
Feb 11, 2026
Fiscal Period
Q3 2026
Normalized EPS / Estimate
24.07/ (23.21 est.)INR
+3.70%beat
Revenue / Estimate
26.04B/ (26.28B est.)INR
-0.93%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
25.85B
24.10B
27.15B
26.04B
Cost of goods sold
9.81B
9.56B
10.73B
9.45B
Cost of revenue
9.81B
9.56B
10.73B
9.45B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.65B
3.40B
3.54B
3.67B
Operating expense
8.21B
8.37B
8.67B
8.87B
Total operating expenses
18.02B
17.93B
19.40B
18.32B
Operating income
7.83B
6.17B
7.75B
7.72B
Other non operating income
-2.24B
800.00M
820.00M
690.00M
EBT including unusual items
8.64B
7.33B
9.12B
7.80B
EBT excluding unusual items
8.63B
7.33B
9.12B
8.54B
Income tax expense
2.02B
1.88B
2.23B
1.97B
Effective tax rate
23.38%
25.65%
24.45%
25.26%
Other operating expenses
3.49B
3.85B
4.00B
4.02B
Net income
6.62B
5.45B
6.89B
5.83B
Net profit margin
25.61%
22.61%
25.38%
22.39%
Earnings per share
24.93
20.49
25.97
24.07
Interest and investment income
2.95B
-
-
-
Interest expense
-10.00M
-30.00M
-80.00M
-60.00M
Net interest expenses
2.94B
-30.00M
-80.00M
-60.00M
Depreciation and amortization charges
1.07B
1.12B
1.13B
1.18B
EBITDA
8.82B
7.16B
8.88B
8.72B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer